Health Condition 1: Z959- Presence of cardiac and vascular implant and graft, unspecified
Conditions
Interventions
Intervention1: Propofol: Dose(0.1 to 0.5 mg/kg/h),
Route of administration- Intravenous infusion,
Duration - 96 hours or until extubation(whichever is earlier)
Control Intervention1: Dexmedetomidine
Sponsors
Dr Mahin Aboobacker B
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients above 18 years of age admitted to AITU. 2.Patients undergoing off pump CABG and other valve surgeries.
Exclusion criteria
Exclusion criteria: 1.Patients undergoing on pump CABG 2.HR less than 50/min 3.MAP less than 65mmHG despite adequate volume resuscitation and vasopressor administration,VIS score more than 10 in post CABG patients and less than 60 mm HG in valve replacement surgeries. 4.Acute severe neurological disorder. 5.Allergy to dexmedetomidine or propofol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare between dexmedetomidine and propofol for sedation on the incidence of new onset atrial fibrillation and atrial fibrillation with fast ventricular rate (in pre-existing atrial fibrillation) in elective post cardiac surgery patients.Timepoint: 96 hours or until extubation(whichever is earlier) | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the length of ICU stayTimepoint: Until in ICU;To compare the volume of cardiac drainsTimepoint: Until in ICU | — |
Countries
India
Contacts
Public ContactDr Chetan Sadashivappa
Narayana Health City
Outcome results
None listed